Peptide record

TPDB11720

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11720
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb
standard
No
A 37-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GVFTLIKGATQLIGKTLGKELGKTGLELMACKITEQC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C172H298N44O51S3
RNDHPSWY
GL
3894.70
9.02
5
3
14
+2
0.18
0.295
108.11
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.03
9
Residue Composition
number
2
A
0
R
0
N
0
D
2
C
3
E
2
Q
6
G
0
H
3
I
6
L
5
K
1
M
1
F
0
P
0
S
5
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 2 E: 3 Q: 2 G: 6 H: 0 I: 3 L: 6 K: 5 M: 1 F: 1 P: 0 S: 0 T: 5 W: 0 Y: 0 V: 1
Chemical Descriptors
37 reviewed residue count
C172H298N44O51S3 sequence-only estimate (linear, free termini)
3894.70 sequence-only estimate (linear, free termini)
9.02 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.18 sequence-only estimate (linear, free termini)
0.295 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3.6 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 2 Activity

Activity

MIC
Antibacterial
3.6 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

ctive against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
3.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

w P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
3.6 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 5 Activity

Activity

MIC
Antifungal
3.6 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ctive against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
3.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

w P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
3.6 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 8 Activity

Activity

MIC
Antiparasitic
3.6 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ctive against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
3.6 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

w P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
3.6 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 11 Activity

Activity

MIC
Antiviral
3.6 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ctive against B. pyocyaneus (now P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
3.6 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

w P. aeruginosa) (MIC 3.6 ug/ml), E. coli (MIC 3.6 ug/ml), S. aureus (MIC 3.6 ug/ml), and C. albicans (MIC 3.6 ug/ml). Updated 7/2021